DNA methylation is a physiological mechanism regulating both gene expression and genomic stability. Abnormal DNA methylation is observed in neoplastic as well as degenerative disease, and may affect both the whole genome and specific genes. Aberrant DNA methylation has been recently associated to the exposure to carcinogenic chemical compounds. The characterization of DNA methylation abnormalities by modern molecular biology methods may allow the development of new molecular biomarkers of early biological effects.
[New molecular indicators for the prevention of tumor and degenerative diseases: anomalous DNA methylation] / De Palma, G; Mozzoni, P. - In: GIORNALE ITALIANO DI MEDICINA DEL LAVORO ED ERGONOMIA. - ISSN 1592-7830. - 31:1(2009), pp. 51-53.
[New molecular indicators for the prevention of tumor and degenerative diseases: anomalous DNA methylation]
Mozzoni, P
2009-01-01
Abstract
DNA methylation is a physiological mechanism regulating both gene expression and genomic stability. Abnormal DNA methylation is observed in neoplastic as well as degenerative disease, and may affect both the whole genome and specific genes. Aberrant DNA methylation has been recently associated to the exposure to carcinogenic chemical compounds. The characterization of DNA methylation abnormalities by modern molecular biology methods may allow the development of new molecular biomarkers of early biological effects.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
